Table 1.
Clinical characteristics of the sample.
| Variable | Control (n = 50) | Intervention (n = 50) | Total Sample (n = 100, Female = 61, Male = 39) | p-Value between Groups |
|---|---|---|---|---|
| Age (years) | 56.86 ± 4.41 | 55.25 ± 2.71 | 56.00 ± 3.35 | 0.404 |
| Total cholesterol (mmol/L) | 3.68 ± 0.95 | 4.127 ± 1.04 | 3.39 ± 0.74 | 0.111 |
| Triglyceride (mmol/L) | 1.48 ± 0.57 | 1.693 ± 0.88 | 1.60 ± 0.78 | 0.125 |
| HbA1c (%) | 6.62 ± 0.67 | 6.59 ± 0.81 | 6.61 ± 74 | 0.584 |
| HDL (mmol/L) | 1.21 ± 0.29 | 1.149 ± 0.30 | 1.20 ± 0.36 | 0.794 |
| LDL (mmol/L) | 2.36 ± 0.70 | 2.3035 ± 0.92 | 2.30 ± 0.78 | 0.443 |
| BMI (kg/m2) | 29.92 ± 4.11 | 28.45 ± 7.69 | 29.22 ± 6.11 | 0.244 |
| Total SF-36 (score) | 284.89 ± 126.72 | 349.16 ± 146.71 | 315.47 ± 138.76 | 0.139 |
| SF-36 mental health | 48.00 ± 17.90 | 54.00 ± 16.20 | 51.00 ± 17.20 | 0.211 |
| Glycemia (mg/dL) | 109.44 ± 14.79 | 104.71 ± 13.16 | 107.38 ± 13.85 | 0.511 |
Abbreviations: BMI, body mass index; HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SF-36, Short Form 36.